In the Aggrastat-to-Zocor (A to Z) Trial, achieved levels of high-sensitivity C-reactive protein (hs-CRP) at 30 days and four months were independently associated with long-term survival and the risk of myocardial infarction (MI).

Authors

• Person: Not available Organization: National Lipid Association
  EBM Tools for Practice: Best Biomarkers for Inflammation

Sources

• EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org National Lipid Association via serper

Referenced by nodes (2)

• high-sensitivity C-reactive protein concept
• myocardial infarction concept